| Back |
|
| In complicated infections, that shows the path is |
| Product Name: |
| Injections |
| Ceftriaxone 125/250/500 mg , 1 & 2 gm injections |
|
| Offers commanding effect in chloramphenicolresistant H. influenzae infection |
| Well-documented in typhoidal and non-typhoidal salmonellosis |
| Highly beneficial for prophylaxis in urological surgery |
| Extends better compliance than penicillin G |
|
| "Using a third generation cephalosporin as first line treatment is effective in dealing with the problem of poor outcomes from meningitis due to Haemophilus influenzae that is resistant to chloramphenicol."
|
| High C-reactive protein (CRP), prolonged high fever and signs of moderate or severe dehydration appear appropriate to define severe cases of Salmonella enterocolitis. Short-course ceftriaxone therapy is clinically beneficial to these patients. Neither clinical nor microbiological relapse was seen after therapy.
|
| " In selected patients undergoing nephrectomy and requiring antimicrobial prophylaxis such as manourished, debilitated, diabetic or immunosuppressed patients, the use of a single dose of ceftriaxone (1000 mg) makes it possible to offer an optimal bacterial coverage for the prevention of postoperative infection. According to our kinetic evaluation, ceftriaxone is potentially a good antibiotic for prophylaxis in urological surgery."
|
| Ceftriaxone and sodium penicillin G were equally effective for the treatment of severe leptospirosis. Once-daily administration and the extended spectrum of ceftriaxone against bacteria provide additional benefits over intravenous penicilin.
|
|
| Indications:
|
| - Nosocomial infections
|
| - Sexually transmitted diseases
|
| - Typhoid
|
| - Skin and soft tissue infections
|
| - Acute otitis media
|
|
Medical Jr.
| Duke T et al., Arch Dis Child. 2003 Jun;88(6): 536-9
|
| Lin TY et al., Acta Paediatr. 2003 May;92(5): 537-40
|
| Leone M et al., J Chemother. 2003 Apr; 15(2): 1939-42
|
| Panaphut T et al., Clin Infect Dis. 2003 Jun 15; 36(12): 1507-13
|
|
| |
|
 |